Thursday, July 18, 2019

Aker BioMarine’s 2018 annual report sees significant ramp-up of strategic investments

Despite challenges in the market, Aker BioMarine increased revenues year on year by 24 percent, from USD 125 million to USD 155 million with 1,28 billion doses of Superba Krill sold worldwide in 2018. In addition, Aker BioMarine helped provide 325 million additional servings of seafood with QRILL Aqua and contributed to the fact that 850,000 dogs could enjoy eating dogfood containing QRILL Pet.
 



Aker BioMarine delivered a net loss of USD 1 million in 2018, driven by significant investments in new technology, science initiatives and people. These investments have been critical to reach the necessary scale in order to grow the krill segment in a very competitive global omega-3 market.


From a business perspective, we met our targets for 2018 with robust performance in all our segments, despite some headwinds in the market. Costs increased more than I ideally would like them to, driven both by external factors, like high fuel prices but also internal elements in order to facilitate the rapid growth and development we are facing. As a result of this, we have strengthened and equipped the organisation with the resources and tools required for future growth,' says Matts Johansen, CEO of Aker BioMarine.

Read the full article on the International Aquafeed website, HERE.

The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the
magazine International Aquafeed which is published by
Perendale Publishers Ltd

For additional daily news from aquaculture around the world: aquaculture-news

No comments:

Post a Comment